4-butyrolactone has been researched along with thromboxane b2 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ko, FN; Liao, CH; Teng, CM; Wu, TS | 1 |
Blikslager, AT; Campbell, NB; Cook, VL; Meyer, CT | 1 |
Aquino, M; Bruno, I; Guerrero, MD; PayĆ”, M; Riccio, R; Terencio, MC | 1 |
Barlow, BM; Blikslager, AT; Curling, A; Davis, JL; Fogle, C; Holland, B; Schirmer, J | 1 |
1 trial(s) available for 4-butyrolactone and thromboxane b2
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Dinoprostone; Horses; Injections, Intravenous; Ointments; Sulfones; Tablets; Thromboxane B2 | 2015 |
3 other study(ies) available for 4-butyrolactone and thromboxane b2
Article | Year |
---|---|
Bakkenolide G, a natural PAF-receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4-Butyrolactone; Adenosine Triphosphate; Animals; Arachidonic Acid; Blood Platelets; Calcium; Collagen; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; In Vitro Techniques; Inositol Phosphates; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sesquiterpenes; Spiro Compounds; Thrombin; Thromboxane B2 | 1997 |
Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
Topics: 4-Butyrolactone; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Eicosanoids; Electrophoresis, Polyacrylamide Gel; Horse Diseases; Horses; Ischemia; Jejunal Diseases; Sulfones; Thromboxane B2 | 2009 |
Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression.
Topics: 4-Butyrolactone; Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Behavior, Animal; Blood Platelets; Cattle; Chronic Disease; Gene Expression Regulation, Enzymologic; Humans; Hyperalgesia; Inflammation; Intramolecular Oxidoreductases; Leukotriene B4; Male; Mice; Neutrophils; Prostaglandin-E Synthases; Thiophenes; Thromboxane B2 | 2009 |